RecruitingPhase 3NCT06003387
28
studies recruiting now
as of 7 Sept 2026
275
studies registered in total
as of 7 Sept 2026
28
countries with a recruiting site
as of 7 Sept 2026
23 Apr 2024
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT04563520
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
RecruitingNCT04398628
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingPhase 3NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
RecruitingPhase 1 / Phase 2NCT06379789
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 28 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Hemophilia B Leyden study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Hemophilia B Leyden
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).